Trial Details
COMPLETEDBasic Information
| Clinical ID | c1072 |
|---|---|
| Identifier | NCT04706793 |
| Trial Title | Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Etrasimod|DRUG: Placebo |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | Nagoya-shi |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2020-12-25 |
|---|---|
| Primary Completion Date | 2022-08-03 |
| Completion Date | 2022-08-03 |